Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma.

Massoumi R, Kuphal S, Hellerbrand C, Haas B, Wild P, Spruss T, Pfeifer A, Fässler R, Bosserhoff AK.

J Exp Med. 2009 Jan 16;206(1):221-32. doi: 10.1084/jem.20082044. Epub 2009 Jan 5.

2.

MicroRNA-9 up-regulates E-cadherin through inhibition of NF-κB1-Snail1 pathway in melanoma.

Liu S, Kumar SM, Lu H, Liu A, Yang R, Pushparajan A, Guo W, Xu X.

J Pathol. 2012 Jan;226(1):61-72. doi: 10.1002/path.2964. Epub 2011 Aug 24.

3.

CYLD inhibits melanoma growth and progression through suppression of the JNK/AP-1 and β1-integrin signaling pathways.

Ke H, Augustine CK, Gandham VD, Jin JY, Tyler DS, Akiyama SK, Hall RP, Zhang JY.

J Invest Dermatol. 2013 Jan;133(1):221-9. doi: 10.1038/jid.2012.253. Epub 2012 Jul 26.

4.

KLF6 Gene and early melanoma development in a collagen I-rich extracellular environment.

Huh SJ, Chen YL, Friedman SL, Liao J, Huang HJ, Cavenee WK, Robertson GP.

J Natl Cancer Inst. 2010 Aug 4;102(15):1131-47. doi: 10.1093/jnci/djq218. Epub 2010 Jul 21.

5.

Downregulation of cylindromatosis gene, CYLD, confers a growth advantage on malignant melanoma cells while negatively regulating their migration activity.

Ishikawa Y, Tsunoda K, Shibazaki M, Takahashi K, Akasaka T, Masuda T, Maesawa C.

Int J Oncol. 2012 Jul;41(1):53-60. doi: 10.3892/ijo.2012.1424. Epub 2012 Apr 2.

PMID:
22469839
6.

Isolation and characterization of spheroid cells from human malignant melanoma cell line WM-266-4.

Na YR, Seok SH, Kim DJ, Han JH, Kim TH, Jung H, Lee BH, Park JH.

Tumour Biol. 2009;30(5-6):300-9. doi: 10.1159/000261073. Epub 2009 Nov 23.

PMID:
19940551
7.

Snail-regulated genes in malignant melanoma.

Kuphal S, Palm HG, Poser I, Bosserhoff AK.

Melanoma Res. 2005 Aug;15(4):305-13.

PMID:
16034310
8.

S100A4 expression with reduced E-cadherin expression predicts distant metastasis of human malignant melanoma cell lines in the NOD/SCID/gammaCnull (NOG) mouse model.

Ikoma N, Yamazaki H, Abe Y, Oida Y, Ohnishi Y, Suemizu H, Matsumoto H, Matsuyama T, Ohta Y, Ozawa A, Ueyama Y, Nakamura M.

Oncol Rep. 2005 Sep;14(3):633-7.

PMID:
16077966
9.

Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling.

Massoumi R, Chmielarska K, Hennecke K, Pfeifer A, Fässler R.

Cell. 2006 May 19;125(4):665-77.

10.

Epigenetic silencing of novel tumor suppressors in malignant melanoma.

Muthusamy V, Duraisamy S, Bradbury CM, Hobbs C, Curley DP, Nelson B, Bosenberg M.

Cancer Res. 2006 Dec 1;66(23):11187-93.

11.

Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression.

Shiraishi K, Yamasaki K, Nanba D, Inoue H, Hanakawa Y, Shirakata Y, Hashimoto K, Higashiyama S.

Oncogene. 2007 Jan 18;26(3):339-48. Epub 2006 Jul 24.

PMID:
16862184
12.

Ethanol inhibits B16-BL6 melanoma metastasis and cell phenotypes associated with metastasis.

Kushiro K, Núñez NP.

In Vivo. 2012 Jan-Feb;26(1):47-58.

PMID:
22210715
13.

SPARC represses E-cadherin and induces mesenchymal transition during melanoma development.

Robert G, Gaggioli C, Bailet O, Chavey C, Abbe P, Aberdam E, Sabatié E, Cano A, Garcia de Herreros A, Ballotti R, Tartare-Deckert S.

Cancer Res. 2006 Aug 1;66(15):7516-23.

14.

Nomilin inhibits metastasis via induction of apoptosis and regulates the activation of transcription factors and the cytokine profile in B16F-10 cells.

Pratheeshkumar P, Raphael TJ, Kuttan G.

Integr Cancer Ther. 2012 Mar;11(1):48-60. doi: 10.1177/1534735411403307. Epub 2011 Jun 10.

PMID:
21665879
15.

Loss of E-cadherin expression in melanoma cells involves up-regulation of the transcriptional repressor Snail.

Poser I, Domínguez D, de Herreros AG, Varnai A, Buettner R, Bosserhoff AK.

J Biol Chem. 2001 Jul 6;276(27):24661-6. Epub 2001 Apr 25.

16.

The FBXO4 tumor suppressor functions as a barrier to BRAFV600E-dependent metastatic melanoma.

Lee EK, Lian Z, D'Andrea K, Letrero R, Sheng W, Liu S, Diehl JN, Pytel D, Barbash O, Schuchter L, Amaravaradi R, Xu X, Herlyn M, Nathanson KL, Diehl JA.

Mol Cell Biol. 2013 Nov;33(22):4422-33. doi: 10.1128/MCB.00706-13. Epub 2013 Sep 9.

17.

Snail1 mediates hypoxia-induced melanoma progression.

Liu S, Kumar SM, Martin JS, Yang R, Xu X.

Am J Pathol. 2011 Dec;179(6):3020-31. doi: 10.1016/j.ajpath.2011.08.038. Epub 2011 Oct 11.

18.

GLI1-dependent transcriptional repression of CYLD in basal cell carcinoma.

Kuphal S, Shaw-Hallgren G, Eberl M, Karrer S, Aberger F, Bosserhoff AK, Massoumi R.

Oncogene. 2011 Nov 3;30(44):4523-30. doi: 10.1038/onc.2011.163. Epub 2011 May 16.

PMID:
21577203
19.

Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration.

Rothhammer T, Poser I, Soncin F, Bataille F, Moser M, Bosserhoff AK.

Cancer Res. 2005 Jan 15;65(2):448-56.

20.

The nitrobenzoxadiazole derivative MC3181 blocks melanoma invasion and metastasis.

De Luca A, Carpanese D, Rapanotti MC, Viguria TM, Forgione MA, Rotili D, Fulci C, Iorio E, Quintieri L, Chimenti S, Bianchi L, Rosato A, Caccuri AM.

Oncotarget. 2017 Feb 28;8(9):15520-15538. doi: 10.18632/oncotarget.14690.

Supplemental Content

Support Center